Related Experiment Video
Updated: Aug 11, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways
Tomoharu Fukumori1, Yukinori Takenaka, Natsuo Oka
1Tumor Progression and Metastasis Program, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
Abstract:
Studies of CD95 (APO-1/Fas), a member of the death receptor family, have revealed that it is involved in two primary CD95 apoptotic signaling pathways, one regulated by the large amount of active caspase-8 (type I) formed at the death-inducing signaling complex and the other by the apoptogenic activity of mitochondria (type II). To date, it is still unclear which pathway will be activated in response to an apoptotic insult. Here, we demonstrate that the antiapoptotic molecule galectin-3, which contains the four amino acid-anti-death-motif (NWGR) conserved in the BH1 domain of the Bcl-2 member proteins, is expressed only in type I cells. Transfection of galectin-3 cDNA into galectin-3 null cells (type II) resulted converting them to type I apoptotic phenotype. In addition, we show that galectin-3 is complexed with CD95 in vivo identifying galectin-3 as a novel CD95-binding partner that determines which of the CD95 apoptotic signaling pathways the cell will select.
Insights
Galectin-3 determines cell fate in CD95 (APO-1/Fas) signaling. This antiapoptotic molecule directs cells toward type I apoptosis, preventing mitochondrial involvement and promoting survival.
Area of Science:
- Cell biology
- Molecular biology
- Immunology
Background:
- CD95 (APO-1/Fas) receptor initiates apoptosis via two distinct pathways: type I (caspase-8 dependent) and type II (mitochondria dependent).
- The specific pathway activated by apoptotic insults remains largely undetermined.
- Galectin-3, an antiapoptotic protein, possesses a conserved motif similar to Bcl-2 family proteins.
Purpose of the Study:
- To investigate the role of galectin-3 in regulating CD95 apoptotic signaling pathways.
- To identify galectin-3 as a potential determinant of type I versus type II apoptosis.
- To explore the interaction between galectin-3 and the CD95 receptor.
Main Methods:
- Cellular expression analysis of galectin-3 in type I and type II apoptotic phenotypes.
- Galectin-3 cDNA transfection into galectin-3 null cells to assess phenotypic changes.
- In vivo co-immunoprecipitation assays to detect galectin-3 and CD95 complex formation.
Main Results:
- Galectin-3 expression was exclusively observed in type I apoptotic cells.
- Transfection of galectin-3 into type II cells induced a type I apoptotic phenotype.
- Galectin-3 was identified as a novel binding partner of CD95 in vivo.
Conclusions:
- Galectin-3 dictates the selection of the CD95 apoptotic signaling pathway.
- Galectin-3 promotes a type I apoptotic response, favoring caspase-8 activation over mitochondrial pathways.
- The interaction of galectin-3 with CD95 is a key mechanism controlling cell death decisions.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Amplifying Signals via Enzymatic Cascade
Intracellular Signaling Affects Focal Adhesions
Some...

